|
MechanismmAChRs antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date13 May 1949 |
100 Clinical Results associated with TAI GUK PHARM Co., Ltd.
0 Patents (Medical) associated with TAI GUK PHARM Co., Ltd.
100 Deals associated with TAI GUK PHARM Co., Ltd.
100 Translational Medicine associated with TAI GUK PHARM Co., Ltd.